$TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis$

TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis

Saved in:

Bibliographic Details
Main Authors:	Ritam Joarder, Dhwani Patel, Atul Tiwari, Jatin Choudhary, Pranaya Vana, Vallish Shenoy, Neha Mer, Anant Ramaswamy, Prabhat Bhargava, Vikas Ostwal
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd.
Series:	South Asian Journal of Cancer
Subjects:	bevacizumab chemotherapy-refractory colorectal cancer TAS-102 tipiracil trifluridine
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1801347
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anticancer effects of PEP06 (TB01) in combination with Trifluridine/Tipiracil (TAS-102) in a xenograft model of human colorectal cancer
by: Ruohong Lin, et al.
Published: (2024-12-01)

Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
by: Carmine Pinto, et al.
Published: (2025-01-01)

Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients
by: Toshiaki Takahashi, et al.
Published: (2025-01-01)

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trialResearch in context
by: Niels A.D. Guchelaar, et al.
Published: (2025-02-01)

Renal impairment as a risk factor for chemotherapy induced neutropenia in the treatment of trifluridine/thymidine phosphorylase inhibitor plus bevacizumab
by: Masatsune Shibutani, et al.
Published: (2025-01-01)

TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer
by: Cheng-Jiang Liu, et al.
Published: (2021-01-01)

Hubungan antara Beban Tas dengan Risiko Skoliosis pada Siswa Kelas 4-6 Sekolah Dasar
by: Komang Trisna Handayani, et al.
Published: (2024-06-01)

Kültür Devriminden “Büyük Terör” e: Çön Taş’taki Siyasi Katliam
by: Hikmet ÖKSÜZ, et al.
Published: (2020-12-01)

To evaluate the efficacy of subconjunctival bevacizumab injection in vascular pterygium before surgical excision in preventing recurrence comparing with bare sclera technique
by: Nusrat Shaheen, et al.
Published: (2025-01-01)

Efficacy of Sub-Conjunctival Injection of Mitomycin C Versus Bevacizumab in Pterygium Treatment: Pakistani Population
by: Amber khalid, et al.
Published: (2025-01-01)

Early postoperative bevacizumab for preventing neovascular glaucoma in phacovitrectomy for proliferative diabetic retinopathy
by: Sunjin Hwang, et al.
Published: (2025-01-01)

Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy
by: Hironori Ochi, et al.
Published: (2025-01-01)

TAS2R38 genotype and CRS severity in children with cystic fibrosis
by: Elena Cantone, et al.
Published: (2025-01-01)

Error exponent for TAS/MRC fading channel
by: Changshui LI
Published: (2016-05-01)

Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis
by: Jie Dai, et al.
Published: (2025-01-01)

Investigation of the effect of intravitreal bevacizumab treatment on left heart function using speckle tracking echocardiography
by: Mehmet Şahinbaş, et al.
Published: (2025-01-01)

Intra-operative Intravitreal Bevacizumab For Patients With Diabetic Macular Edema Undergoing Phacoemulsification with Foldable IOL Implantation
by: Haider Ali Chaudhry, et al.
Published: (2024-06-01)

Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan
by: Jaekyung Cheon, et al.
Published: (2025-01-01)

Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
by: Parissa Tabrizian, et al.
Published: (2025-02-01)

Biochanin a modulates steroidogenesis and cellular metabolism in human granulosa cells through TAS2Rs activation: a spotlight on ovarian function
by: Francesca Paola Luongo, et al.
Published: (2025-01-01)

Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review
by: Ke Chen, et al.
Published: (2025-02-01)

The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naïve primary stage IVB cervical cancer
by: Junhwan Kim, et al.
Published: (2025-01-01)

Evaluation of the association between bevacizumab concentration and clinical outcomes in patients with breast cancer brain metastasis
by: Chih-Ning Cheng, et al.
Published: (2025-01-01)

Pituitary adenoma: literature review and association with TAS2R16 (rs978739, rs1357949) gene polymorphisms
by: E. Pileckaitė, et al.
Published: (2023-10-01)

Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
by: Qinyuan Gong, et al.
Published: (2025-01-01)

Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
by: Meng Wu, et al.
Published: (2025-02-01)

Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
by: Qinyuan Gong, et al.
Published: (2025-01-01)

IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG?
by: S. V. Orlov, et al.
Published: (2016-06-01)

Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
by: Hossein Ashraf, et al.
Published: (2025-06-01)

Chapter 3: Variety Selection
by: Donald N. Maynard, et al.
Published: (2019-05-01)

Florida Crop/Pest Management Profile: Herbs (Basil, Cilantro, Dill, Mint, Parsley, Rosemary, Sage, Thyme)
by: Mark A. Mossler
Published: (2005-12-01)

Golden Canna: Canna flaccida
by: Edward F. Gilman, et al.
Published: (2015-09-01)

Preventing Foodborne Illness:Listeriosis
by: Keith R. Schneider, et al.
Published: (2003-07-01)

A Beginner’s Guide to Water Management — Symbols, Abbreviations & Conversion Factors
by: Florida LAKEWATCH
Published: (2004-03-01)

Diagnostic and Monitoring Serology in Commercial Poultry Integrations: Practical Applications
by: Gary D. Butcher
Published: (2003-10-01)

Chapter 3: Variety Selection
by: Donald N. Maynard, et al.
Published: (2019-05-01)

Preventing Foodborne Illness: Listeriosis
by: Keith R. Schneider, et al.
Published: (2009-08-01)

Posters and Fliers
by: Ricky Telg
Published: (2010-09-01)

Recreational Harvesting of the Florida Bay Scallop, Citrus County
by: Don Sweat, et al.
Published: (2011-08-01)

Healthy Living: Reliable Web Sites
by: Linda B. Bobroff, et al.
Published: (2009-08-01)